IFNγ works synergistically with EBNA2 to induce PD-L1 on EBV+ tumor cells [74]; the immunosuppressive cytokine IL-10 acts as critical pathway in suppressing the host’s antiviral T cell response [75]. The gene discussed is IFNG; the disease is neoplasm.